Hatem Azim, MD, chief medical officer at Emergence Therapeutics, and Marcela Mazo Canola, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss if patients can interrupt endocrine therapy to attempt pregnancy.
The latest news updates from the 2024 Symposium
//
Estimated Read Time:
Hatem Azim, MD, chief medical officer at Emergence Therapeutics, and Marcela Mazo Canola, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss if patients can interrupt endocrine therapy to attempt pregnancy.